Stator 40 Tablet

Description

Stator 40 Tablet contains Atorvastatin (40mg), a medicine from the statin group that helps lower cholesterol and triglycerides in the blood. It reduces the risk of heart disease, stroke, and related complications by blocking the enzyme responsible for cholesterol production in the liver.

The 40mg strength is generally prescribed for patients with severe high cholesterol levels or those who need intensive lipid-lowering therapy because lower doses (10mg or 20mg) were not sufficient.

---

Uses

• Treatment of high cholesterol (hypercholesterolemia, mixed dyslipidemia)

• Prevention of heart attack and stroke in high-risk individuals

• Slows progression of atherosclerosis (plaque build-up in arteries)

• Cardiovascular protection in patients with diabetes, hypertension, obesity, or family history of heart disease

---

How to Use

• Take the tablet orally with water, usually once daily, preferably in the evening.

• Can be taken with or without food.

• Continue following a cholesterol-lowering diet, exercise, and lifestyle changes while on treatment.

• Do not stop the medicine suddenly without consulting your doctor.

---

Side Effects

Common side effects:

• Constipation, indigestion, gas, stomach pain

• Headache, dizziness, sleep disturbances

• Muscle pain or joint pain

Serious but rare side effects:

• Muscle damage (rhabdomyolysis) – severe muscle pain, weakness, dark urine

• Liver problems – yellowing of eyes/skin, dark urine, persistent nausea

• Allergic reactions – rash, swelling, difficulty breathing

---

Precautions

• Avoid alcohol consumption to reduce risk of liver injury.

• Not safe for pregnant or breastfeeding women.

• Inform your doctor if you have liver disease, kidney disease, thyroid disorder, or history of muscle problems.

• Routine blood tests for cholesterol levels and liver function are recommended.

---

Key Ingredient Recap

• Atorvastatin (40mg): A high-dose statin that lowers LDL cholesterol and triglycerides, raises HDL, and significantly reduces cardiovascular risks